Molecular characterization of severe and mild cases of influenza A (H1N1) 2009 strain from Argentina.

While worldwide pandemic influenza A(H1N1) pdm case fatality rate (CFR) was 0.4%, Argentina's was 4.5%. A total of 34 strains from mild and severe cases were analyzed. A full genome sequencing was carried out on 26 of these, and a partial sequencing on the remaining eight. We observed no evidence that the high CFR can be attributed to direct virus changes. No evidence of re-assortment, mutations associated with resistance to antiviral drugs, or genetic drift that might contribute to virulence was observed. Although the mutation D225G associated with severity in the latest reports from the Ukraine and Norway is not observed among the Argentine strains, an amino acid change in the area (S206T) surrounding the HA receptor binding domain was observed, the same previously established worldwide.

[1]  Jianpeng Ma,et al.  Evolutionary Trends of A(H1N1) Influenza Virus Hemagglutinin Since 1918 , 2009, PloS one.

[2]  Ten Feizi,et al.  Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray , 2009, Nature Biotechnology.

[3]  P. Barboza,et al.  Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[4]  M. Deem,et al.  The epitope regions of H1-subtype influenza A, with application to vaccine efficacy , 2009, Protein engineering, design & selection : PEDS.

[5]  E. Lyons,et al.  Pandemic Potential of a Strain of Influenza A (H1N1): Early Findings , 2009, Science.

[6]  Daniel H. Huson,et al.  Dendroscope: An interactive viewer for large phylogenetic trees , 2007, BMC Bioinformatics.

[7]  David L. Hirschberg,et al.  Detection of Respiratory Viruses and Subtype Identification of Influenza A Viruses by GreeneChipResp Oligonucleotide Microarray , 2007, Journal of Clinical Microbiology.

[8]  David E. Swayne,et al.  A Two-Amino Acid Change in the Hemagglutinin of the 1918 Influenza Virus Abolishes Transmission , 2007, Science.

[9]  Yang Liu,et al.  Panmicrobial Oligonucleotide Array for Diagnosis of Infectious Diseases , 2007, Emerging infectious diseases.

[10]  W. Ian Lipkin,et al.  Greene SCPrimer: a rapid comprehensive tool for designing degenerate primers from multiple sequence alignments , 2006, Nucleic acids research.

[11]  P. Palese,et al.  Influenza A Virus PB1-F2 Protein Contributes to Viral Pathogenesis in Mice , 2006, Journal of Virology.

[12]  James C Paulson,et al.  Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. , 2006, Journal of molecular biology.

[13]  Ian A. Wilson,et al.  Structure of the Uncleaved Human H1 Hemagglutinin from the Extinct 1918 Influenza Virus , 2004, Science.

[14]  D. J. Stevens,et al.  The Structure and Receptor Binding Properties of the 1918 Influenza Hemagglutinin , 2004, Science.

[15]  Y. Guan,et al.  Universal primer set for the full-length amplification of all influenza A viruses , 2001, Archives of Virology.